Muscle Relaxant Drugs Market Size, & Forecast

Report Description
Table Of Content
List of Tables
List of Figures

Muscle relaxant drugs are used to treat painful muscle spasms such as a headache, stiff neck, or backache. Both OTC and prescription muscle relaxants are available in the market and are being used by consumers suffering from muscle-related problems. Norflex, Zanaflex, Cip-Zox, Soma, Fexmid, and Robaxin are some common relaxants available in the market. Apart from this, the global muscle relaxant drugs market reached a market valuation of USD XX.X Million in 2018 and is estimated to grow at a CAGR of XX.X% during the forecast period, i.e., 2019-2024.

Market Insights

Growth Drivers – Muscle Relaxant Drugs Market

Strong Prevalence of Muscle Related Health Issues

About 80 percent of adults experience low back pain at some point in their lifetimes. Muscle related issues can affect people of all ages, from adolescents to the elderly. Muscle pain caused in several conditions such as sprain ligaments, strain muscles, rupture disks, and irritate joints, all of these can lead to back pain. Such muscle pain issues are rising at horrifying pace among consumers, and this can be attributed to their fast, competitive, and unhealthy lifestyle. Arthritis, poor posture, obesity, and psychological stress are several other reasons, which are very common these days, which are causing muscle pain in people. Further, this strong growth in penetration of muscle pain issues across the globe is likely to foster the demand for muscle relaxant drugs around the world.

Growing Geriatric Population

Muscle pain is widespread in older adults. Older people suffer from many conditions such as polymyalgia rheumatic through their aging period, which causes muscle pain and stiffness in the upper arms, shoulders, thighs, and pelvic girdle. Furthermore, the world’s older population continues to grow at an unprecedented rate, and currently, 9 percent of people worldwide are aged 65 and over. As the world’s older population continues to grow at an unprecedented rate, it is expected that the demand for muscle relaxant drugs will rise in coming years.

Barriers – Muscle Relaxant Drugs Market

Miss conceptions among the population and chances of severe side effects such as habituation and respiratory arrest due to the consumption of muscle relaxant drugs are significant barriers in the growth of global muscle relaxant drugs market. Also, the abuse potential of muscle relaxant drugs is another challenge confronting the growth of global muscle relaxant drugs market.

Request For Specific Country/Regional Market Report Click Here

Muscle Relaxant Drugs Market to Surpass USD 1.6 Billion by 2024, Fostered by Growing Prevalence of Muscle Related Health Issues

Request Sample

Segmentation Analysis

The muscle relaxant drugs market is segmented in different categories, including by drug type, by route of administration, by drug class and by retail sales channel. The market is segmented by drug type into facial muscle relaxant, skeletal muscle relaxant and neuromuscular relaxant. Among this segment, the skeletal muscle relaxant drug segment is expected to capture significant shares of the market in 2018. Global muscle relaxant drugs product segment was totaled at USD XXX.X billion in 2018 and is projected to reach USD XXX.X billion in 2024 at a CAGR of XX.X% from 2019 to 2024. Moreover, based on the route of administration, the muscle relaxant drugs market is further sub-segmented into oral and injectable segments. The oral muscle relaxant drugs dominated the market with a leading share of XX% in 2018 and is poised to continue this dominance in coming years to reach at XX% by 2024. Apart from above to segment, the report is also fractioned into drug class (peripherally acting muscle relaxants and centrally acting muscle relaxants) and retail sales channel (Drug Stores, Hospitals, Clinics, Online Stores) segments.

Geographical Analysis

Regionally, the report offers an analysis of North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. When it comes to muscle relaxant drugs market, North America is the leader in Muscle Relaxant Drugs market. The North America region has acquired significant market shares and is poised to continue its dominance in the coming years. One-half of all working Americans admit to having back pain symptoms each year and low-back pain costs Americans at least $50 billion in health care costs each year. This strong prevalence of muscle related diseases in America is likely to allow this region to retain its leading position in coming years.

Competitive Analysis

The report also covers detailed competitive analysis of major market players of the global muscle relaxant drugs market, such as Johnson & Johnson, Abbott Laboratories, Medtronic Inc., Pfizer, Novartis International AG, Cipla Limited, Mallinckrodt plc, Par Pharmaceutical, Inc., Endo Pharmaceuticals, Inc., Orient Pharma Co., Ltd. and other major & notable players. Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by business segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).

Segmentation

By Drug Type

- Facial Muscle Relaxant

- Skeletal Muscle Relaxant

- Neuromuscular Relaxant

By Route of Administration:

- Oral

- Injectable

By Drug Class

- Peripherally Acting Muscle Relaxants

- Centrally Acting Muscle Relaxants

By Retail Sales Channel

- Drug Stores

- Hospitals

- Clinics

- Online Stores

By Geography

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)

- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)

- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Competitive Landscape

The report profiles various major market players such as:

Johnson & Johnson
Abbott Laboratories
Medtronic Inc.
Pfizer
Novartis International AG
Cipla Limited
Mallinckrodt plc
Par Pharmaceutical, Inc.
Endo Pharmaceuticals, Inc.
Orient Pharma Co., Ltd.
Other Major & Niche Players

The study also provides a company’s positioning and market share in Muscle Relaxant Drugs market.

Timeline Considered for Analysis:

- 2018: Base Year

- 2019: Estimated Year

- 2019 to 2024: Forecast Period

Research Scope and Deliverables

Overview & Executive Summary

Market Drivers, Trends, Challenges and Opportunities

Market Size and Forecast Projections

Macroeconomic Indicators of Various Countries Impacting the Growth of the Market

Extensive Coverage of Industry Players including Recent Product Launches and Market Activities

Porter’s Five Force Analysis

Market Segmentation Analysis:

Industry report analyzes the global muscle relaxant drugs market by the following segments:

- Drug Type

- Route of Administration

- Drug Class

- Retail Sales Channel

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Muscle Relaxant Drugs Industry Report

What is the overall market size in 2018? What will be the market growth during the forecast period i.e. 2019-2024?
Which region would have high demand for product in the upcoming years?
What are the factors driving the growth of the market?
Which sub-market will make the most significant contribution to the market?
What are the market opportunities for existing and entry-level players?
What are various long-term and short-term strategies adopted by the market players?

Research Methodology

Market Definition and List of Abbreviations

1. Executive Summary
2. Growth Drivers & Issues in Global Muscle Relaxant Drugs Market
2.1. North America
2.2. Europe
2.3. Asia Pacific
2.4. Europe
2.5. Middle East & Africa

3. Global Muscle Relaxant Drugs Market Trends
4. Opportunities in Global Muscle Relaxant Drugs Market
5. Recent Industry Activities, 2018
6. Porter's Five Forces Analysis
7. Macro-Economic Trends
8. Market Value Chain and Supply Chain Analysis
9. Global Muscle Relaxant Drugs Market Value (USD Million), 2018-2024

10. Global Muscle Relaxant Drugs Market Segmentation Analysis, By Drug Type
10.1. Introduction
10.2. Market Attractiveness, By Drug Type
10.3. BPS Analysis, By Drug Type
10.4. Facial Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
10.5. Skeletal Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
10.6. Neuromuscular Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

11. Global Muscle Relaxant Drugs Market Segmentation Analysis, By Route of Administration
11.1. Introduction
11.2. Market Attractiveness, By Route of Administration
11.3. BPS Analysis, By Route of Administration
11.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
11.5. Injectable Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

12. Global Muscle Relaxant Drugs Market Segmentation Analysis, By Drug Class
12.1. Introduction
12.2. Market Attractiveness, By Drug Class
12.3. BPS Analysis, By Drug Class
12.3.1. Peripherally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
12.3.2. Centrally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

13. Global Muscle Relaxant Drugs Market Segmentation Analysis, By Retail Sales Channel
13.1. Introduction
13.2. Market Attractiveness, By Retail Sales Channel
13.3. BPS Analysis, By Retail Sales Channel
13.4. Drug Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
13.5. Hospitals Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
13.6. Clinics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
13.7. Online Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14. Geographical Analysis
14.1. Introduction
14.2. North America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.2.1. By Drug Type
14.2.1.1. Introduction
14.2.1.2. Market Attractiveness, By Drug Type
14.2.1.3. BPS Analysis, By Drug Type
14.2.1.4. Facial Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.2.1.5. Skeletal Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.2.1.6. Neuromuscular Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.2.2. By Route of Administration
14.2.2.1. Introduction
14.2.2.2. Market Attractiveness, By Route of Administration
14.2.2.3. BPS Analysis, By Route of Administration
14.2.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.2.2.5. Injectable Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.2.3. By Drug Class
14.2.3.1. Introduction
14.2.3.2. Market Attractiveness, By Drug Class
14.2.3.3. BPS Analysis, By Drug Class
14.2.3.3.1. Peripherally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.2.3.3.2. Centrally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.2.4. By Retail Sales Channel
14.2.4.1. Introduction
14.2.4.2. Market Attractiveness, By Retail Sales Channel
14.2.4.3. BPS Analysis, By Retail Sales Channel
14.2.4.4. Drug Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.2.4.5. Hospitals Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.2.4.6. Clinics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.2.4.7. Online Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.2.5. By Country
14.2.5.1. Market Attractiveness, By Country
14.2.5.2. BPS Analysis, By Country
14.2.5.3. U.S. Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.2.5.4. Canada Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.3. Europe Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.1. By Drug Type
14.3.1.1. Introduction
14.3.1.2. Market Attractiveness, By Drug Type
14.3.1.3. BPS Analysis, By Drug Type
14.3.1.4. Facial Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.1.5. Skeletal Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.1.6. Neuromuscular Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.3.2. By Route of Administration
14.3.2.1. Introduction
14.3.2.2. Market Attractiveness, By Route of Administration
14.3.2.3. BPS Analysis, By Route of Administration
14.3.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.2.5. Injectable Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.3.3. By Drug Class
14.3.3.1. Introduction
14.3.3.2. Market Attractiveness, By Drug Class
14.3.3.3. BPS Analysis, By Drug Class
14.3.3.3.1. Peripherally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.3.3.2. Centrally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.3.4. By Retail Sales Channel
14.3.4.1. Introduction
14.3.4.2. Market Attractiveness, By Retail Sales Channel
14.3.4.3. BPS Analysis, By Retail Sales Channel
14.3.4.4. Drug Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.4.5. Hospitals Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.4.6. Clinics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.4.7. Online Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.3.5. By Country
14.3.5.1. Market Attractiveness, By Country
14.3.5.2. BPS Analysis, By Country
14.3.5.3. Germany Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.5.4. United Kingdom Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.5.5. France Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.5.6. Italy Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.5.7. Spain Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.5.8. Russia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.3.5.9. Rest of Europe Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.4. Asia Pacific Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.1. By Drug Type
14.4.1.1. Introduction
14.4.1.2. Market Attractiveness, By Drug Type
14.4.1.3. BPS Analysis, By Drug Type
14.4.1.4. Facial Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.1.5. Skeletal Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.1.6. Neuromuscular Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.4.2. By Route of Administration
14.4.2.1. Introduction
14.4.2.2. Market Attractiveness, By Route of Administration
14.4.2.3. BPS Analysis, By Route of Administration
14.4.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.2.5. Injectable Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.4.3. By Drug Class
14.4.3.1. Introduction
14.4.3.2. Market Attractiveness, By Drug Class
14.4.3.3. BPS Analysis, By Drug Class
14.4.3.3.1. Peripherally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.3.3.2. Centrally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.4.4. By Retail Sales Channel
14.4.4.1. Introduction
14.4.4.2. Market Attractiveness, By Retail Sales Channel
14.4.4.3. BPS Analysis, By Retail Sales Channel
14.4.4.4. Drug Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.4.5. Hospitals Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.4.6. Clinics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.4.7. Online Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.4.5. By Country
14.4.5.1. Market Attractiveness, By Country
14.4.5.2. BPS Analysis, By Country
14.4.5.3. China Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.5.4. India Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.5.5. Japan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.5.6. South Korea Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.5.7. Indonesia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.5.8. Taiwan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.5.9. Australia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.5.10. New Zealand Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.4.5.11. Rest of Asia Pacific Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.5. Latin America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.1. By Drug Type
14.5.1.1. Introduction
14.5.1.2. Market Attractiveness, By Drug Type
14.5.1.3. BPS Analysis, By Drug Type
14.5.1.4. Facial Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.1.5. Skeletal Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.1.6. Neuromuscular Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.5.2. By Route of Administration
14.5.2.1. Introduction
14.5.2.2. Market Attractiveness, By Route of Administration
14.5.2.3. BPS Analysis, By Route of Administration
14.5.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.2.5. Injectable Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.5.3. By Drug Class
14.5.3.1. Introduction
14.5.3.2. Market Attractiveness, By Drug Class
14.5.3.3. BPS Analysis, By Drug Class
14.5.3.3.1. Peripherally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.3.3.2. Centrally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.5.4. By Retail Sales Channel
14.5.4.1. Introduction
14.5.4.2. Market Attractiveness, By Retail Sales Channel
14.5.4.3. BPS Analysis, By Retail Sales Channel
14.5.4.4. Drug Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.4.5. Hospitals Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.4.6. Clinics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.4.7. Online Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.5.5. By Country
14.5.5.1. Market Attractiveness, By Country
14.5.5.2. BPS Analysis, By Country
14.5.5.3. Brazil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.5.4. Mexico Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.5.5.5. Rest of Latin America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.6. Middle East & Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.1. By Drug Type
14.6.1.1. Introduction
14.6.1.2. Market Attractiveness, By Drug Type
14.6.1.3. BPS Analysis, By Drug Type
14.6.1.4. Facial Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.1.5. Skeletal Muscle Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.1.6. Neuromuscular Relaxant Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.6.2. By Route of Administration
14.6.2.1. Introduction
14.6.2.2. Market Attractiveness, By Route of Administration
14.6.2.3. BPS Analysis, By Route of Administration
14.6.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.2.5. Injectable Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.6.3. By Drug Class
14.6.3.1. Introduction
14.6.3.2. Market Attractiveness, By Drug Class
14.6.3.3. BPS Analysis, By Drug Class
14.6.3.3.1. Peripherally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.3.3.2. Centrally Acting Muscle Relaxants Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.6.4. By Retail Sales Channel
14.6.4.1. Introduction
14.6.4.2. Market Attractiveness, By Retail Sales Channel
14.6.4.3. BPS Analysis, By Retail Sales Channel
14.6.4.4. Drug Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.4.5. Hospitals Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.4.6. Clinics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.4.7. Online Stores Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

14.6.5. By Geography
14.6.5.1. Market Attractiveness, By Geography
14.6.5.2. BPS Analysis, By Geography
14.6.5.3. GCC Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.5.4. North Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.5.5. South Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024
14.6.5.6. Rest of Middle East & Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), 2018-2024

15. Competitive Landscape
15.1. Market Share of Key Players15.2. Market Positioning of Major Players in Global Muscle Relaxant Drugs Market
15.3. Company Profiles
15.3.1. Johnson & Johnson
15.3.1.1. Company Overview
15.3.1.2. Product Offered
15.3.1.3. Business Strategy
15.3.1.4. Financials
15.3.1.5. SWOT Analysis
15.3.1.6. Market Share Analysis
15.3.1.7. Key Achievements & Developments
15.3.2. Abbott Laboratories
15.3.3. Medtronic Inc.
15.3.4. Pfizer
15.3.5. Novartis International AG
15.3.6. Cipla Limited
15.3.7. Mallinckrodt plc
15.3.8. Par Pharmaceutical, Inc.
15.3.9. Endo Pharmaceuticals, Inc.
15.3.10. Orient Pharma Co., Ltd.
15.3.11. Other Major & Niche Players

16. Disclaimer